Can autism’s core traits be separated from cognitive ability? A new study in Nature reveals that a gene called PTCHD1-AS specifically influences social interaction and repetitive behaviors without impacting learning or memory. This discovery provides a “molecular pattern” for developing treatments that target the hallmark features of autism spectrum disorder (ASD) while sparing intellectual function.
The Research
Led by Dr. Stephen Scherer at The Hospital for Sick Children (SickKids) and involving data from over 9,300 individuals, the study analyzed genomic deletions in the X-linked gene PTCHD1-AS. They found that deletions were associated with increased ASD susceptibility in males (females have a backup X chromosome). In mouse models, males lacking PTCHD1-AS showed altered social behavior and increased repetitive actions, but normal learning, memory, and attention. This gene is a long non-coding RNA (lncRNA), which regulates other genes, unlike the ~100 other ASD-linked genes that encode proteins. The researchers traced the behavioral effects to reduced protein kinase C activity in a circuit connecting the cortex to the striatum, a brain region controlling repetitive behaviors, along with altered synaptic plasticity and myelination.
Why It Matters
This finding is significant because it isolates the biological mechanisms of autism’s core traits from broader cognitive development. Most existing autism-linked genes affect many brain functions, making targeted therapies difficult. PTCHD1-AS offers a specific entry point for future precision treatments aimed solely at social and repetitive behaviors, leaving cognition intact. For individuals on the spectrum or their families, this research underscores that autism’s challenges are not tied to intelligence, and it opens doors to therapies that may one day address specific behaviors without affecting other abilities.
What You Can Do
If you or a loved one is on the autism spectrum, focus on strengths in learning and memory while seeking support for social or repetitive behaviors. Stay informed about emerging therapies targeting specific genetic pathways, such as those involving PTCHD1-AS, and discuss them with your healthcare provider. Understanding your unique cognitive profile can help you advocate for personalized approaches.
Source: Neuroscience News
Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.
